These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31047049)

  • 21. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.
    Li X; Qin F; Yang L; Mo L; Li L; Hou L
    Int J Nanomedicine; 2014; 9():3971-85. PubMed ID: 25170267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
    Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
    J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.
    Chen D; Zhang G; Li R; Guan M; Wang X; Zou T; Zhang Y; Wang C; Shu C; Hong H; Wan LJ
    J Am Chem Soc; 2018 Jun; 140(24):7373-7376. PubMed ID: 29799737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
    Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coloaded Nanoparticles of Paclitaxel and Piperlongumine for Enhancing Synergistic Antitumor Activities and Reducing Toxicity.
    Liu Q; Zhao D; Zhu X; Chen H; Yang Y; Xu J; Zhang Q; Fan A; Li N; Guo C; Kong Y; Lu Y; Chen X
    J Pharm Sci; 2017 Oct; 106(10):3066-3075. PubMed ID: 28552690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.
    Lian T; Peng M; Vermorken AJ; Jin Y; Luo Z; Van de Ven WJ; Wan Y; Hou P; Cui Y
    J Nanosci Nanotechnol; 2016 Jun; 16(6):6258-64. PubMed ID: 27427699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
    Yang X; Cai X; Yu A; Xi Y; Zhai G
    J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
    Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.
    Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z
    Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
    Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
    Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
    Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
    Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
    J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
    Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
    Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
    Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
    Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.